HL Financial Services LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,821 shares of the healthcare conglomerate’s stock after selling 82 shares during the period. HL Financial Services LLC’s holdings in UnitedHealth Group were worth $2,267,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Dodge & Cox acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Harris Associates L P increased its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock valued at $762,041,000 after buying an additional 14,489 shares during the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of UnitedHealth Group by 6.2% in the first quarter. UBS Asset Management Americas Inc. now owns 4,372,898 shares of the healthcare conglomerate’s stock valued at $717,199,000 after buying an additional 255,799 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in shares of UnitedHealth Group by 9.0% in the first quarter. American Century Companies Inc. now owns 4,022,002 shares of the healthcare conglomerate’s stock valued at $659,649,000 after buying an additional 333,338 shares during the last quarter. 86.37% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Incorporated (NYSE UNH) traded down 0.04% during trading on Wednesday, reaching $194.83. 2,125,671 shares of the company’s stock traded hands. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The company has a market cap of $191.91 billion, a PE ratio of 23.41 and a beta of 0.64. The company has a 50 day moving average price of $187.91 and a 200-day moving average price of $173.50.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. During the same period last year, the business earned $1.96 EPS. The company’s revenue was up 7.7% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “HL Financial Services LLC Sells 82 Shares of UnitedHealth Group Incorporated (NYSE:UNH)” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://stocknewstimes.com/2017/08/09/hl-financial-services-llc-sells-82-shares-of-unitedhealth-group-incorporated-nyseunh-updated.html.
Several analysts have issued reports on UNH shares. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Friday, May 19th. Deutsche Bank AG reissued a “buy” rating and issued a $187.00 price objective (up previously from $183.00) on shares of UnitedHealth Group in a research note on Saturday, April 22nd. Mizuho raised their price objective on shares of UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research note on Tuesday, April 18th. Vetr raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a research note on Tuesday, May 30th. Finally, CIBC raised their price objective on shares of UnitedHealth Group from $186.00 to $187.00 and gave the stock an “outperform” rating in a research note on Monday, April 24th. One analyst has rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and an average target price of $200.24.
In related news, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total value of $913,200.00. Following the transaction, the director now directly owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the transaction, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The disclosure for this sale can be found here. Insiders sold a total of 15,540 shares of company stock worth $2,873,320 over the last 90 days. Company insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.
